Quantitative Imaging for Radiation Oncology.

[1]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.

[2]  P. Lambin,et al.  Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  W. Oyen,et al.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  R. Hermans,et al.  Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma , 2010, European Radiology.

[5]  Marit Holden,et al.  Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI. , 2012, Cancer research.

[6]  Jan-Jakob Sonke,et al.  The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Michael Baumann,et al.  Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  Timothy D Johnson,et al.  Multi‐system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice‐water phantom , 2013, Journal of magnetic resonance imaging : JMRI.

[9]  Eric J. W. Visser,et al.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[11]  E. Yorke,et al.  FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer. , 2015, Lung cancer.

[12]  Eric S Paulson,et al.  Consensus opinion on MRI simulation for external beam radiation treatment planning. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  W. Oyen,et al.  EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  Joint Head and Neck Radiotherapy-MRI Development Cooperative.  A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations , 2017 .

[15]  Bradley J Beattie,et al.  Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  M. Alber,et al.  Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  B. Loo,et al.  18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy. , 2018, International journal of radiation oncology, biology, physics.

[18]  Kenneth A. Iczkowski,et al.  Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer , 2018, International journal of radiation oncology, biology, physics.

[19]  K. Haustermans,et al.  Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  D. Jaffray,et al.  Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with 18F-Fluoroazomyin Arabinoside. , 2018, International journal of radiation oncology, biology, physics.

[21]  Julian C. Hong,et al.  Association of Interim FDG-PET Imaging During Chemoradiation for Squamous Anal Canal Carcinoma With Recurrence. , 2018, International journal of radiation oncology, biology, physics.

[22]  Christian Kirisits,et al.  The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies , 2018, Clinical and translational radiation oncology.

[23]  J. Stoker,et al.  Evaluation of Six Diffusion-weighted MRI Models for Assessing Effects of Neoadjuvant Chemoradiation in Pancreatic Cancer Patients. , 2018, International journal of radiation oncology, biology, physics.